Extracranial relapse of an anaplastic oligodendroglioma in an adolescent: Case report and review of the literature

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 5, 2007, Pages 319-322

  Bruggers, Carol ^a,b   White, Keith ^a   Zhou, Holly ^a   Chen, Zhong ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Adolescent; Anaplastic oligodendroglioma; Chemotherapy; Extracranial relapse

Indexed keywords

ANGIOGENESIS INHIBITOR; CARBOPLATIN; CELECOXIB; CYCLOPHOSPHAMIDE; ETOPOSIDE; IRINOTECAN; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; THALIDOMIDE; VINCRISTINE;

ADRENAL METASTASIS; AGED; ANAPLASTIC CARCINOMA; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CASE REPORT; CHROMOSOME 19Q; CHROMOSOME 1P; CLINICAL FEATURE; HETEROZYGOSITY LOSS; HUMAN; LUNG METASTASIS; MALE; MEDIASTINUM METASTASIS; MULTIPLE CYCLE TREATMENT; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; WHOLE BODY CT;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; OLIGODENDROGLIOMA; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE;

EID: 34248226456     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318054756e     Document Type: Review

References (14)

1. Phillip Pizzo DP. Principles and Practice of Pediatric Oncology. 4th ed. Philidelphia, New York: Lippencott-Raven; 2002.
2. Black P McL, Loeffler JS. Cancer of the Central Nervous System. Cambridge, Massachusetts: Blackwell Science Inc; 1997.
3. Cairncross JG. Aggressive oligodendroglioma: a chemosensitive tumor. Recent Results Cancer Res. 1994;135:127-133.
4. Paleologos NA, Macdonald DR, Vick NA, et al. Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma. Neurology. 1999;53:1141-1143.
5. Dawson TP. Pancytopaenia from a disseminated anaplastic oligodendroglioma. Neuropathol Appl Neurobiol. 1997;23:516-520.
6. Liwnicz BH, Rubinstein LJ. The pathways of extraneural spread in metastasizing gliomas. Hum Pathol. 1979;10:453-469.
7. Newman HF, Howard GC, Reid PM. Metastatic oligodendroglioma presenting as a leukoerythroblastic anaemia. Eur J Surg Oncol. 1985;11:287-288.
8. Hardman JM, Earls KM. Metastasizing neuroectodermal tumors of the central nervous system. J Neurosurg. 1968;31:50-58.
9. Anand M, Kumar R, Jain P, et al. Metastatic anaplastic oligodendroglioma simulating acute leukemia. A case report. Acta Cytol. 2003;47:467-469.
10. Sharma A, Agarwal A, Sharma MC, et al. Bone marrow metastasis in anaplastic oligodendroglioma. Int J Clin Pract. 2003;57:351-352.
11. Araki M, Fan J, Haraoka S, et al. Extracranial metastasis of anaplastic ganglioglioma through a ventriculoperitoneal shunt: a case report. Pathol Int. 1999;49:258-263.
12. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 1998;90:1473-1479.
13. Jenkins RB, Curran W, Scott CB, et al. Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group. Am J Clin Oncol. 2001;24:506-508.
14. Bello MJ, Leone PE, Vaquero J, et al. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer. 1995;64:207-210.